What is the Treatment for Hypercalcemia of Malignancy?
Treatment focuses on lowering serum calcium levels and addressing the underlying cancer. Common therapeutic approaches include:
- Intravenous Fluids to promote renal calcium excretion - Bisphosphonates to inhibit bone resorption - Calcitonin for short-term calcium reduction - Denosumab, a monoclonal antibody that targets RANKL, reducing bone resorption - Chemotherapy or targeted therapy to treat the primary cancer